Ontario court approves AstraZeneca/Fusion acquisition plan

seekingalpha06-01

Fusion Pharmaceuticals (NASDAQ:FUSN) said the Ontario Superior Court of Justice has approved its statutory plan of arrangement to be acquired by a wholly owned subsidiary of AstraZeneca (NASDAQ:AZN). ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2440249169?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1317445462/image_1317445462.jpg","is_english":true,"pubTime":"2024-06-01 06:06","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2440249169","market":"hk","top_or_hot":-1,"title":"Ontario court approves AstraZeneca/Fusion acquisition plan","media":"seekingalpha","content":"<div>\n<p>Fusion Pharmaceuticals (NASDAQ:FUSN) said the Ontario Superior Court of Justice has approved its statutory plan of arrangement to be acquired by a wholly owned subsidiary of AstraZeneca (NASDAQ:AZN). ...</p>\n\n<a href=\"https://seekingalpha.com/news/4112111-ontario-court-approves-astrazenecafusion-acquisition-plan\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ontario court approves AstraZeneca/Fusion acquisition plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOntario court approves AstraZeneca/Fusion acquisition plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-01 06:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4112111-ontario-court-approves-astrazenecafusion-acquisition-plan><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fusion Pharmaceuticals (NASDAQ:FUSN) said the Ontario Superior Court of Justice has approved its statutory plan of arrangement to be acquired by a wholly owned subsidiary of AstraZeneca (NASDAQ:AZN). ...</p>\n\n<a href=\"https://seekingalpha.com/news/4112111-ontario-court-approves-astrazenecafusion-acquisition-plan\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QID","symbol_name":"纳指两倍做空ETF","start_time":0,"source_url":"https://seekingalpha.com/news/4112111-ontario-court-approves-astrazenecafusion-acquisition-plan","article_id":"2440249169","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1317445462/image_1317445462.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2440249169","pubTimestamp":1717193200,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Fusion Pharmaceuticals  said the Ontario Superior Court of Justice has approved its statutory plan of arrangement to be acquired by a wholly owned subsidiary of AstraZeneca . Under the arrangement, Fusion shareholders will receive $21 per share upfront plus a deferred payment of $3 per share in the form of a contingency right value when a certain regulatory milestone is achieved. Fusion shareholders approved the roughly $2B merger earlier this week. The deal is expected to close in Q2, after which Fusion’s common shares will be delisted from Nasdaq.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QID":"纳指两倍做空ETF","FSNB.U":"Fusion Acquisition Corp. II","FUSN":"Fusion Pharmaceuticals Inc.","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","PSQ":"纳指反向ETF","QLD":"纳指两倍做多ETF","BK4007":"制药","BK4585":"ETF&股票定投概念","SQQQ":"纳指三倍做空ETF","BK4139":"生物科技","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","AZN":"阿斯利康","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4568":"美国抗疫概念","BK4588":"碎股","QQQ":"纳指100ETF","FUSE.U":"Fusion Acquisition",".IXIC":"NASDAQ Composite","TQQQ":"纳指三倍做多ETF","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC"},"translate_title":"安大略省法院批准阿斯利康/Fusion收购计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":1,"FUSN":1,"FUSE.U":1,"FSNB.U":1,".IXIC":0.9,"TQQQ":0.6,"SQQQ":0.6,"QQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"NQmain":0.6,"MNQmain":0.6},"content_text":"Fusion Pharmaceuticals (NASDAQ:FUSN) said the Ontario Superior Court of Justice has approved its statutory plan of arrangement to be acquired by a wholly owned subsidiary of AstraZeneca (NASDAQ:AZN). Under the arrangement, Fusion shareholders will receive $21 per share upfront plus a deferred payment of $3 per share in the form of a contingency right value when a certain regulatory milestone is achieved. Fusion shareholders approved the roughly $2B merger earlier this week. The deal is expected to close in Q2, after which Fusion’s common shares will be delisted from Nasdaq.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2440249169"}